Clinical and Experimental Rheumatology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.2 | Q2 | 65.5% | 1.038 | Q2 | 84.9% |
| 2024 | 3.3 | Q2 | 72.4% | 1.004 | Q2 | 84.3% |
| 2023 | 3.4 | Q2 | 71.9% | 0.907 | Q2 | 83.1% |
| 2022 | 3.7 | Q3 | 63.6% | 0.975 | Q2 | 85.7% |
| 2021 | 4.9 | Q2 | 73.1% | 1.123 | Q1 | 88.9% |
| 2020 | — | — | 1.184 | Q2 | 88.7% | |
| 2019 | — | — | 1.121 | Q2 | 88.0% | |
| 2018 | — | — | 1.257 | Q1 | 88.8% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1593-098X
ISSN
0392-856X
country
ITcoverage
1983-2026